Abbott | ABT - Pre Tax Profit


Abbott reported $2.39B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Agilent USD 364M 78M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Bio-Rad Laboratories USD 929.2M 846.3M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 192.2M 75.4M Dec/2025
Danaher USD 1.24B 138M Mar/2026
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 169.23M 25.24M Dec/2025
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Medtronic USD 2.45B 1.04B Mar/2026
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Pfizer USD 5.18B 6.82B Mar/2026
Smith & Nephew USD 469M 70M Dec/2025
Solventum Corp USD 332M 179M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
Terumo JPY 31.67B 13.71B Mar/2026
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025